Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziziphus jujuba, ginseng, and famotidine for prevention of post-surgical abdominal adhesions
IRCT20220115053713N3Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ginseng and famotidine in adhesive intestinal obstruction (ASBO), sponsored by Mashhad University of Medical Sciences. Started Feb 2023; status: completed.
02
Drugs
ginsengfamotidine
03
Conditions
adhesive intestinal obstruction (ASBO)
Beyond the preview
Go deeper on IRCT20220115053713N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220115053713N3.